• 3634 Citations
  • 32 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joseph Tuscano is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 3634 Citations
  • 32 h-Index
  • 82 Article
  • 2 Letter
  • Belinostat in Relapsed/Refractory T-Cell Large Granular Lymphocyte Leukemia

    Poh, C., Arora, M., Ghuman, S. & Tuscano, J., Jan 1 2020, (Accepted/In press) In : Acta Haematologica.

    Research output: Contribution to journalArticle

  • A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction

    Takebe, N., Beumer, J. H., Kummar, S., Kiesel, B. F., Dowlati, A., O'Sullivan Coyne, G., Piekarz, R., Rubinstein, L., Fogli, L. K., Vaishampayan, U., Goel, S., O'Bryant, C. L., El-Rayes, B. F., Chung, V., Lenz, H. J., Kim, R., Belani, C. P., Tuscano, J., Schelman, W., Moore, N. & 2 others, Doroshow, J. H. & Chen, A. P., Jan 1 2019, (Accepted/In press) In : British Journal of Clinical Pharmacology.

    Research output: Contribution to journalArticle

    Open Access
  • A phase I study of the combination of rituximab and ipilimumab in patients with relapsed/ refractory B-cell lymphoma

    Tuscano, J. M., Maverakis, E., Groshen, S., Tsao-Wei, D., Luxardi, G., Merleev, A. A., Beaven, A., DiPersio, J. F., Popplewell, L., Chen, R., Kirschbaum, M., Schroeder, M. A. & Newman, E. M., Dec 1 2019, In : Clinical Cancer Research. 25, 23, p. 7004-7013 10 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations